Abionyx Pharma SA (ABNX) — Cash Flow Quality Index

Latest as of June 2019: -1.02x

Abionyx Pharma SA (ABNX) has a Cash Flow Quality Index of -1.02x as of June 2019. Operating cash flow of €-2.96 Million is below net income of €2.90 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore total assets of Abionyx Pharma SA for the complete picture of this company's asset base.

Cash Flow Quality Index

-1.02x
Operating CF / Net Income

Operating Cash Flow

€-2.96 Million
EUR

Net Income

€2.90 Million
EUR

Data as of

Jun 2019
Most recent filing

Abionyx Pharma SA Cash Flow Quality Index (2019–2019)

Historical Cash Flow Quality Index for Abionyx Pharma SA across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check ABNX goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Annual Cash Flow Quality Index for Abionyx Pharma SA (2019–2019)

Year-by-year earnings quality comparison for Abionyx Pharma SA. For live market cap and the full company financial profile, see market value of Abionyx Pharma SA.

Year Quality Index Operating CF (EUR) Net Income YoY Change
2019 -2.14x €-3.95 Million €1.85 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.